Search results
Results from the WOW.Com Content Network
A Lyme disease vaccine has entered phase 3 clinical trials, per Pfizer. Here's how the vaccine works, when it might become available, and who it might benefit.
Pfizer, the maker of a COVID-19 vaccine, announced Monday it is starting a phase 3 clinical trial on its Lyme disease vaccine, known as VLA15. The study will include over 6,000 participants from ...
Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years -- in hopes of better fighting the tick-borne threat.
NDV-HXP-S (known as ButanVac [2] [3] or ADAPTCOV [4] in Brazil, COVIVAC [5] in Vietnam, HXP-GPOVac [6] in Thailand, Patria [7] in Mexico) is a COVID-19 vaccine candidate developed under the leadership of Peter Palese, Adolfo García-Sastre, and Florian Krammer at the Icahn School of Medicine at Mount Sinai.
Madeley is a village and ward in the Borough of Newcastle-under-Lyme, North Staffordshire, England. It is split into three parts: Madeley, Middle Madeley, and Little Madeley. Madeley Heath is also considered by many to be part of Madeley. In the 2001 census, the population was recorded as 4,386, [1] decreasing to 4,222 at the 2011 Census. [2]
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
If phase 3 pans out, they may have the first Lyme vaccine in 20 years. 20 years ago, a Lyme-disease vaccine was taken off the market. Now, 2 companies are developing one that could be available by ...
Sep. 21—Researchers developing a Lyme disease vaccine are seeking local residents to participate in a clinical trial. "There's so much more to be discovered," Dr. Jackson Booth said of how ...